PMID: 6159595Apr 11, 1980Paper

Physical mapping of the globin gene deletion in hereditary persistence of foetal haemoglobin (HPFH)

Nucleic Acids Research
R Bernards, R A Flavell

Abstract

We have mapped the globin gene region in the DNA of two HPFH patients. In a patient homozygous for the G gamma A gamma type of HPFH at least 24 kb of DNA in the globin gene region has been deleted to remove most of the gamma-delta intergenic region and the delta and beta globin genes. The 5' break point of the deletion is located about 9 kb upstream from the delta globin gene. The 3' break point has not been precisely located but is at least 7 kb past the beta globin gene. DNA from an individual heterozygous for the Greek (A gamma) type of HPFH, however, shows no detectable deletion in the entire gamma delta beta-globin gene region. HPFH, therefore, appears to occur in different molecular forms. These results are discussed in terms of a model for the regulation of globin gene expression in man.

Citations

Jan 1, 1985·Human Genetics·S E AntonarakisS H Orkin
Oct 1, 1989·Biochemical Genetics·M E Foreman, J E Womack
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C H LangleyW F Quattlebaum
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T LundR A Flavell
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S OttolenghiA M Gianni
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M C Carroll, R R Porter
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R D Campbell, R R Porter
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A J Brown
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·F S CollinsS M Weissman
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S W ChungD H Chui
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P GunningT Shows
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E SolomonR Dalgleish
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A WeydertJ L Guénet
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C C KanG Fey
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P S HenthornO Smithies
Apr 25, 1985·Nucleic Acids Research·M W JenningsD J Weatherall
Jul 10, 1987·Nucleic Acids Research·M PonczS Surrey
Oct 18, 2005·Molecular and Cellular Biology·Dirk Haussecker, Nicholas J Proudfoot
Mar 1, 1981·The Journal of Clinical Investigation·S H OrkinD G Nathan
Aug 1, 1983·The Journal of Clinical Investigation·M PirastuC T Holbrook
Oct 1, 1985·The Journal of Clinical Investigation·P CurtinH Lehmann
Nov 8, 2005·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Urvashi Bhardwaj, Edward R B McCabe
Sep 20, 1985·Journal of Molecular Biology·K HencoJ Schmid
Apr 15, 1982·Journal of Molecular Biology·A J JeffreysA C Boyd
Jul 5, 1981·Journal of Molecular Biology·P A BarrieA F Scott
Jun 1, 1982·Cell·P Borst, G A Cross
Apr 15, 1983·Virology·N HeisterkampJ R Stephenson
Jan 1, 1989·Annals of the New York Academy of Sciences·S H Boyer
Feb 1, 1985·British Journal of Haematology·P S HenthornT H Huisman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.